Knock-out of specific DMD gene isoforms in the parental hESC line SA001 using CRISPR/Cas9

Laure Chatrousse1, Thifaine Poullion1, Hamel Mahiou2

  • 1CECS, I-STEM, AFM, Neuroplasticity and Therapeutics, 91100 Corbeil-Essonnes, France.

Stem Cell Research
|January 7, 2026
PubMed

Insights

Researchers investigated the role of dystrophin in brain development by disrupting key isoforms in human embryonic stem cells. This study sheds light on dystrophinopathies and their neurodevelopmental impacts.

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Dystrophinopathies, including Duchenne Muscular Dystrophy (DMD), are genetic disorders linked to the DMD gene and dystrophin protein.
  • DMD primarily affects skeletal muscles due to loss of the DP427 isoform, but also presents with poorly understood neurocognitive and neurodevelopmental issues.

Purpose of the Study:

  • To investigate the specific roles of brain-expressed dystrophin isoforms (DP427, DP140, DP71) in neural development.
  • To establish a cellular model for studying the neurodevelopmental aspects of dystrophinopathies.

Main Methods:

  • Utilized CRISPR/Cas9 gene editing technology.
  • Disrupted three key dystrophin isoforms (DP427, DP140, DP71) in a male human embryonic stem cell line (SA001).

Main Results:

  • Successfully generated a human embryonic stem cell line with targeted disruptions of specific dystrophin isoforms.
  • This model allows for the study of how individual dystrophin isoforms contribute to neural development.

Conclusions:

  • The study provides a novel cellular model to explore the neurobiological functions of dystrophin isoforms.
  • This research is crucial for understanding the neural underpinnings of dystrophinopathies and developing targeted therapies.